Dixon Hubard Feinour & Brown Inc Bristol Myers Squibb CO Transaction History

Dixon Hubard Feinour & Brown Inc

$842 Million
Q2 2022

A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 62,172 shares of BMY stock, worth $2.91 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

62,172

Previous 64,897 4.2%

Holding current value

$2.91 Million

Previous $4.74 Million 1.01%

% of portfolio

0.57%

Previous 0.47%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $197,889 - $217,945	-2,725 Reduced 4.2%	62,172 $4.79 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $232,701 - $279,030	3,785 Added 6.19%	64,897 $4.74 Million
Q4 2021 Jan 10, 2022	BUY	$53.63 - $62.52 $429,576 - $500,785	8,010 Added 15.08%	61,112 $3.81 Million
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $946 - $1,108	16 Added 0.03%	53,102 $3.14 Million
Q2 2021 Aug 23, 2021	SELL	$61.91 - $67.42 $125,058 - $136,188	-2,020 Reduced 3.67%	53,086 $3.55 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $56,847 - $63,936	-958 Reduced 1.71%	55,106 $3.48 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $12,921 - $14,319	-225 Reduced 0.4%	56,064 $3.38 Million
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $43,581 - $50,951	795 Added 1.43%	56,289 $3.35 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $136,462 - $198,311	-2,941 Reduced 5.03%	55,494 $3.09 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $5,413 - $7,060	-110 Reduced 0.19%	58,435 $3.75 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $4,277 - $5,071	100 Added 0.17%	58,545 $2.97 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $69,874 - $77,266	-1,566 Reduced 2.61%	58,445 $2.65 Million
Q1 2019 May 17, 2019	SELL	$45.12 - $53.8 $28,651 - $34,163	-635 Reduced 1.05%	60,011 $2.86 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $72,896 - $94,528	-1,495 Reduced 2.41%	60,646 $3.15 Million
Q3 2018 Nov 06, 2018	SELL	$55.19 - $62.25 $78,645 - $88,706	-1,425 Reduced 2.24%	62,141 $3.86 Million
Q2 2018 Jul 25, 2018	SELL	$50.53 - $62.98 $43,304 - $53,973	-857 Reduced 1.33%	63,566 $3.52 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $161,184 - $185,556	2,690 Added 4.36%	64,423 $4.08 Million
Q4 2017 Feb 20, 2018	BUY	$59.94 - $65.35 $42,617 - $46,463	711 Added 1.17%	61,733 $3.78 Million
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $3.37 Million - $3.89 Million	61,022	61,022 $3.89 Million

Others Institutions Holding BMY

# of Institutions

2,801

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.

Account

Dixon Hubard Feinour & Brown Inc Bristol Myers Squibb CO Transaction History